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elucidation of in vitro cellular steps 
induced by antitumor treatment 
with plasma-activated medium
Julie Chauvin1,3, Laure Gibot  2, Elena Griseti1,2, Muriel Golzio  2, Marie-Pierre Rols2, 
Nofel Merbahi1 & patricia Vicendo3
Numerous studies have reported cold atmospheric plasma cytotoxic activities in various cancer cell 
lines, either by direct exposure to non-thermal plasma or indirectly by activating a medium (plasma-
activated medium, PAM) prior to cell treatment. We suggested the use of in vitro 3D tumor model 
spheroids to determine the potential of PAM for cancer therapy at the tissue scale, especially in human 
tumor tissue. This work aimed to better understand the effect of PAM on human colorectal tumor 
spheroids by describing the in vitro-induced-cell death kinetics and associated mechanisms to further 
improve its therapeutic potential. Tumor spheroid growth was delayed depending on contact time with 
PAM. Medium osmolarity was increased by activation with low temperature Helium plasma jet but it did 
not fully explain the observed growth delay. PAM impaired tumor cell viability through intracellular ATP 
depletion, leading within hours to both cell apoptosis and necrosis as well as mitochondrial oxidative 
stress. When successive treatments were spaced over time, cumulative effects on the growth delay of 
spheroids were observed. Taken together, these results demonstrated that plasma-activated liquids 
may represent a novel and efficient therapeutic method for the treatment of tumors, especially when 
successive treatments are applied.
In 2012, 1.4 million new cases of colorectal cancer and 700 000 associated deaths were registered, making it the 
third most diagnosed cancer worldwide1. Currently, the main effective treatments are surgery associated with 
chemotherapy and/or radiotherapy. However, the side effects and drug resistance of these cancer therapies are 
responsible for a lack of efficacy. To counteract these negative effects, new methods to treat colorectal cancers 
involving the production of a high level of reactive oxygen species (ROS) have emerged2,3.
Under physiological conditions, ROS, controlled by antioxidant molecules, are essential for maintaining cel-
lular functions and homeostasis. In contrast, under pathological processes such as colorectal cancer, there is 
an excessive level of ROS due to an imbalance between ROS and nonenzymatic and enzymatic antioxidants. 
Numerous studies have shown that a high level of ROS over the toxic threshold can lead to the preferential killing 
of cancer cells while not affecting normal cells4.
In this area of ROS anticancer therapy, cold atmospheric plasmas have received growing interest. Indeed, for 
biomedical applications, atmospheric pressure plasma in various configurations has been designed, such as the 
Dielectric Barrier Discharge (DBD)5–7 and corona discharge8,9, with different carrier gases such as argon10,11 or 
helium12–14, without or with oxygen15–17.
Their first medical applications of these plasmas were in the disinfection and healing of wounds, but plasmas 
are now increasingly studied for their anti-cancer properties. Several studies have reported their cytotoxic activi-
ties in various cancer cell lines, such as breast cancer10,12, oral cavity squamous cell carcinoma15, ovarian clear-cell 
carcinoma11, prostate cancer16, head and neck cancer18–20 and colorectal cancer13,21.
Two main approaches are being investigated in plasma cancer treatment, namely, directly exposing cells or 
tissue to the plasma jet22,23 or indirectly by activating a medium that will later be put into contact with tumors 
cells4,10,13,20,24. Plasma-activated medium (PAM) offers the advantage of being produced beforehand as a “drug” 
that can be stably stocked for several days13 and is easily usable for direct injection into target tissues. PAM can 
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effectively kill tumor cells or tissues just as direct plasma exposure does. Plasma, as the fourth state of matter, 
reacts with its environment and produces reactive oxygen and nitrogen oxide species (RONS). RONS, such as 
hydrogen peroxide, nitrite and nitrate, have been identified as reactive species playing a major role in cancer cell 
death4,10,14,25,26. However, even if the PAM anti-cancer activities are mainly due to the presence of species such as 
H2O2, NO3−, or NO2−, the presence of RONS is not sufficient to fully explain the cytotoxic effects of PAM. Most of 
the in vitro studies performed on cell culture monolayers showed that PAM mainly induced cell death via apopto-
sis induction10,11,15,17,21. Recently, in vivo studies demonstrated that PAM is able to significantly reduce xenograft 
tumors in mouse models of pancreatic and ovarian cancers27,28. Due to these aspects, PAM may be considered as 
a potential anti-cancer agent. However, the small number of in vivo studies carried out with PAM does not allow 
the therapeutic protocol for tumor treatment to be defined. To predict and improve the performance of PAM as 
an in vivo antitumor treatment, investigations carried out in vitro in a 3D tumor model are necessary. 3D tissue 
models, such as tumor spheroids, are closer to the in vivo context by reproducing the architecture of a tumor29–31 
and can help to elucidate mechanisms underlying the antitumor properties of PAM. Indeed, similar to the avas-
cular regions of tumors, spheroids present gradients of oxygen, nutrients and metabolites, producing a gradient 
in cell proliferation from the center, with the presence of a necrotic core, to the proliferative surface32. Thus, the 
spheroid model is a useful tool to determine the biological effects of PAM on human tumor cell growth. While 
tumor spheroids have been widely used in numerous fields of biology, only a few studies have investigated the 
cellular-induced mechanisms associated with PAM. Thus, spheroids will help determine the potential of plasma 
for cancer therapy at the tissue scale, especially in human tissues.
This work aimed to better understand the sequence of processes involved in the cytotoxicity of the 
plasma-activated medium in spheroids and to thereby provide insight into methods to increase its potential as 
an anticancer treatment. Experiments were performed in vitro in human colorectal tumor spheroids. ATP levels 
were measured using luminescence analysis, and fluorescence microscopy was used to detect membrane integrity, 
caspases activities, and the presence of superoxide in the mitochondria. Finally, the best combination of succes-
sive treatments to efficiently reduce tumor growth was investigated.
Results
Medium osmolarity is increased by low-temperature helium plasma jet exposure. With the set-
tings applied to produce helium plasma-activated medium, an increase in osmolarity was observed (Table 1). Indeed, 
nontreated cell culture medium has an osmolarity of 295 ± 1.5 mosmol/kg while it increased to 358 ± 23 mosmol/kg 
after 120 seconds of exposure to a helium plasma jet. Since osmolarity can modify cell behavior, an osmolarity con-
trol was added to the subsequent experiments, named “gas alone”. It was produced by cell culture medium exposure 
to helium flow alone, without plasma production, for 300 seconds. Under these conditions, medium exposed to gas 
flow alone presented an osmolarity of 360 ± 26 mosmol/kg, similar to the osmolarity of PAM.
Activation of medium with plasma can cause changes in the pH of the medium33 however, in our experimental 
setup, the differences in pH were negligible before and after plasma activation due to the use of a buffered cell 
culture solution. However, we measured that the osmolarity was significantly increased, probably due to medium 
evaporation because of helium flow. Interestingly, the regulation of osmolarity is a promising research path in the 
field of cancer treatment34.
Spheroid growth is delayed by increasing contact time with PAM. The macroscopic aspect of sphe-
roids was observed by wide-field microscopy over 24 h after exposure to non-activated medium (control), gas alone 
(osmolarity control) or PAM with different contact times, TContact (10 min, 4 h or 24 h; Fig. 1A). TContact is the dura-
tion for which spheroids were immersed in PAM. At the macroscopic scale, spheroid integrity was preserved when 
exposed over 24 h to medium treated with helium only (gas alone) or for 10 min with PAM, in accordance with the 
control condition. In contrast, when exposed to PAM for more than 10 min, the spheroid margins became blurry 
and started to disintegrate. Two distinct components appeared, namely, a cohesive core surrounded by a crown of 
detached cells. For spheroids in contact with PAM for 24 h, macroscopic effects were observed as soon as 4 h and up 
to 8 h posttreatment, whereas spheroids in contact with PAM for 4 h only showed deleterious effects at 24 h. Thus, 
the deleterious effects exerted by PAM on spheroid integrity depend on contact time.
Following the growth of the cohesive core of spheroids over three days allowed estimation of the PAM treat-
ment effect on tumor cell growth in 3D (Fig. 1B). For conditions inducing cell detachment (i.e., Tcontact 4 h and 
24 h), evidence of spheroid decay was observed during the first 24 h, followed by a resumption of growth depend-
ing on the time of contact with PAM (Fig. 1A).
For subsequent in vitro experiments, the longer exposure of spheroids to PAM (Tcontact 24 h) was chosen since 
this exposure time induced the most drastic effects on spheroids as early as 8 h after treatment. Interestingly, even a 
pH
Osmolarity 
(mosmol/kg)
Volume after 
exposition (±1 µL)
Medium 7,5 295 ± 2 100
Medium exposed to gas alone for 120 s 7,5 319 ± 3 92
Medium exposed to plasma for 120 s (PAM) 7,5 358 ± 23 80
Medium exposed to gas alone for 300 s 7,5 360 ± 26 80
Table 1. Characterization of media exposed to plasma and gas alone in terms of pH and osmolarity (mosmol/
kg) after exposition to Helium plasma jet. At least 6 independent measurements were conducted. Data are 
expressed as mean ± SD.
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5-min exposure to helium alone had no effect on the macroscopic aspects of spheroids within 24 h. After three days 
of culture, spheroid growth was significantly reduced compared with that of nontreated spheroids but to a less extent 
than that associated with PAM treatment. This result means that spheroid modifications induced by PAM are not 
due to a hyperosmotic effect but mainly to the generation of oxidative compounds, as reported in the literature14,35.
Unlike studies with cells grown in monolayers20, a unique PAM treatment is not sufficient to induce complete 
destruction of spheroids, probably due to their 3D architecture36,37. To optimize therapeutic protocols, an accurate 
description of the kinetics of the cellular mechanisms induced by PAM is needed.
PAM impairs tumor cell viability as observed by intracellular ATP depletion and later mitochon-
drial dysfunction. ATP is generally considered as a good indicator of cell viability38,39. For 24 h, we quantified 
the ATP content of spheroids after PAM treatment (Tcontact 24 h). Figure 2A shows the spheroid’s ATP levels in 
PAM. The ATP was calculated based on a normalization of treated spheroids with regard to the control sphe-
roids. While osmolarity control did not affect the ATP content of spheroids, PAM induced a significant and rapid 
intracellular depletion of ATP within spheroids (Fig. 2A). Two phases were observed: a fast phase during the first 
3 h of exposure, leading to a 50% loss of ATP in spheroids, followed by a slower phase until reaching a 75% loss 
of ATP at the end of the 24 h experiment. Since PAM is known to produce reactive oxygen and nitrogen species, 
the stability of a standard ATP was checked when exposed to PAM in an acellular context (Fig. 2B). No effect was 
observed after exposure of ATP to PAM, meaning that the intracellular decrease of ATP in spheroids exposed to 
PAM is due to a cellular effect. To determine whether the dramatic decrease in intracellular ATP was due to ATP 
leakage or release, ATP was also quantified in the supernatant. Interestingly, no ATP was detected in the super-
natant under these experimental conditions over the 24-h period (data not shown). This result means that either 
ATP is significantly consumed intracellularly or it is no longer efficiently produced by the mitochondria.
Mitochondria dysfunction was evaluated using the MitoSOX fluorescent probe, which specifically detects the 
presence of mitochondrial superoxide. Interestingly, this probe is exclusively sensitive to superoxide and not to 
other ROS or RNS. As soon as 6 h after exposure to PAM, the MitoSOX signal significantly increased, indicating 
the production of mitochondrial superoxide (Fig. 3A). After 22 h of exposure to PAM, strong MitoSOX labeling 
was observed in the detached outer layers of the spheroid (Fig. 3B). Superoxide is known to induce oxidative 
stress, cellular damage and death40. We previously reported that the addition of superoxide dismutase (SOD) 
within PAM reduced DNA damage in outer spheroid layers, highlighting the key role of superoxide13.
Figure 1. Human tumor spheroids macroscopic aspect and growth curve after PAM treatment. (A) 
Macroscopic aspect of spheroids observed by wide-field microscopy for 24 h after PAM exposition or exposition 
to gas alone as osmolarity control. Arrows indicate cell detachment in crown. Scale bar 100 µm. (B) Spheroids 
growth over three days after contact time Tcontact with PAM for 10 minutes, 4 h and 24 h. *p < 0, 05.
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PAM induced cell death through both apoptosis and necrosis. Plasma membrane integrity was 
checked over time with a non-permeant fluorescent probe: propidium iodide. When the plasma membrane 
is altered, propidium iodide penetrates cells and intercalates in DNA, becoming highly fluorescent due to the 
increase in its fluorescence quantum yield. Non-selective permeability of plasma membranes is mainly a hallmark 
of dying cells. Figure 4A shows that membrane integrity was lost between 4 and 6 h of exposure to PAM. An anal-
ysis using videomicroscopy allowed real-time analysis of propidium iodide penetration (Fig. 4B and Movie 1). 
This analysis confirmed that membrane dysfunction is a very rapid phenomenon occurring approximately 6 h 
after exposure to PAM. Osmolarity control (gas alone) did not affect membrane integrity. As mentioned, a loss 
of plasma membrane integrity is mainly associated with cell death by both necrosis and apoptosis. Apoptosis 
was first assessed by quantifying the early externalization of phosphatidylserine by flow cytometry in propid-
ium iodide negative cells (Fig. 4C). Cells in spheroids exposed to PAM displayed a rapid, i.e., within the first 
hour of treatment, transient and significant externalization of phosphatidylserine, which disappeared after longer 
Figure 2. PAM treatment induced loss of ATP. (A) Intracellular spheroid’s content in ATP measured by 
luminescence over the time after exposition to PAM. Blue square: osmolarity control gas alone. Red circle: 
spheroids Tcontact 24 h to PAM. (B) ATP stability in PAM (red circles) or in control non-activated medium (black 
triangle). ns: non-significant.
Figure 3. PAM treatment induced mitochondrial dysfunction through mitochondrial superoxide production. 
(A) Follow-up of the mitochondrial superoxide apparition in control and PAM-120 s spheroids over 22 h. 
The dotted line indicated when spheroids were exposed to PAM. (B) Fluorescence imaging of mitochondrial 
superoxide by wide field microscopy after Tcontact of 22 h to PAM. Scale bar: 300 µm.
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incubation times. Apoptosis was then confirmed via the activation of executioner caspases 3/7 after spheroid 
exposure to PAM, as shown in Fig. 4D. Apoptosis was detectable after 6 h of exposure to PAM and increased over 
time. Interestingly, no apoptosis was observable with the osmolarity control (gas alone). It should be noted that 
the crown of detached and detaching cells is highly fragile. Thus, only in situ wide-field fluorescence microscopy 
within the cell culture dish was performed to assess propidium iodide penetration and apoptosis induction. This 
means that fluorescence coming from the whole spheroid (cohesive core + crown of detached cells) was detected. 
To assess the modification of the cohesive core induced by PAM 24 h post-treatment, spheroids were gently pipet-
ted to allow removal of the crown of detached cells (Fig. 4E). Under both the control and PAM conditions, the 
remaining core of the spheroids did not present a loss of plasma membrane integrity or apoptosis induction, high-
lighting its viability. These results provide evidence that cells constituting the crown of detached cells underwent 
PAM-induced apoptosis and necrosis. This result corresponds to the decrease in size observed 24 h after exposure 
to PAM on the growth curve (Fig. 1B).
The concomitant occurrence of apoptosis and loss of membrane integrity indicates that PAM treatment 
induced both apoptosis and necrosis in spheroids. Apoptosis and necrosis were shown to be limited to cells 
detaching from the spheroid surface, namely, those in close contact with PAM. To amplify the destruction of 
tumor spheroids and target deeper layers, we performed successive treatments with PAM.
Figure 4. PAM treatment induced loss of plasma cell integrity and apoptosis. (A) Plasma membrane 
integrity observed thanks to propidium iodide (red) penetration. Scale bar: 100 µm. (B) Quantification by 
videomicroscopy of propidium iodide fluorescence in spheroid over the time after exposition to non-activated 
medium (black circles), PAM (red squares) or gas alone treatment (blue triangles). (C) Quantification by flow 
cytometry of apoptosis (Annexin-V positive/propidium iodide PI negative cells) through early externalization 
of phosphatidylserine in cells isolated from spheroids exposed for 1 h, 4 h or 6 h to PAM. (D) Caspases 3/7 
activity observed by wide-field fluorescence microscopy after PAM or gas alone treatment or in control 
condition. (E) Propidium iodide penetration and caspases 3/7 activity observed by wide-field fluorescence 
microscopy 24 h after exposure to PAM in cohesive spheroid’s core. Crown of detached cells was removed by 
gentle pipetting. Scale bar: 100 µm. **p < 0.005, ns: non-significant.
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Successive treatments induced a cumulative effect on the growth delay of spheroids. We 
showed that within 24 h, spheroids exposed to PAM presented a crown of necrosis and apoptosis-dying cells and 
a viable cohesive core. We hypothesize that successive exposure to fresh PAM would help stop tumor growth and/
or destroy tumor spheroids.
For that purpose, batches of spheroids were exposed to fresh PAM one, two or three times, and their growth 
was followed over 9 days. Figure 5 shows the volumes of spheroids after they underwent treatment every day 
(Fig. 5A) or every two days (Fig. 5B). Successive treatments performed every day (Fig. 5A) showed that although 
a volume loss is present the day following treatment, after 5 days, each condition (from one to three successive 
treatments) yielded the same spheroid volume. This result suggested that successive treatment one day apart is not 
sufficient to increase the PAM anticancer effect more than one treatment does.
In a similar manner, when performing successive treatment two days apart (Fig. 5B), after each exposure to 
fresh PAM, a reduction in spheroid size was observed, but growth started again within the following 24 h. Two 
successive exposures helped maintain tumor volume, but growth recovered 24 h later. Encouragingly, three suc-
cessive treatments reduced the spheroid volume to less than the original volume. Spheroids treated successively 3 
times were significantly smaller than those treated only twice. This experiment demonstrates a cumulative effect 
of successive PAM treatments with the possibility of not only limiting tumor spheroid growth but also reducing 
tumor size. This in vitro result demonstrated the importance of waiting for cell death mechanisms to be induced 
and completed before performing subsequent PAM treatment.
Discussion
The aim of this work was to better elucidate the effects of PAM on human 3D colorectal tumor spheroids by 
describing the in vitro-induced cell death kinetics and mechanisms to improve its in vivo therapeutic potential. 
The main cellular steps are summarized in Fig. 6.
We have historically made the choice to activate cell culture medium with cold plasma, and we performed a 
detailed assessment of the medium by several complementary analytical techniques to determine the different 
reactive oxygen species, such as hydroxyl radical, superoxide anion, and singlet oxygen, and nitrogen species pro-
duced14, both in water and cell culture medium. We observed that the composition of the medium significantly 
impacted the pH of the solution during plasma treatment, as well as the stability and reactivity with biomolecules 
of the different ROS and RONS produced. However, it should be noted that several other types of liquids, such as 
water and PBS, have been plasma-activated, characterized in terms of the reactive species produced, and tested 
in terms of anticancer properties in vitro or in vivo41–43. These two liquids may be more suitable for translational 
applications in clinics. Most of the reactive oxygen and nitrogen species are found in all these plasma-activated 
liquids but in different quantities depending on the liquid and the plasma experimental set up used.
We previously showed that PAM displayed a genotoxic effect on human tumor cells, mainly by the production 
of reactive oxygen species such as hydrogen peroxide (H2O2) and the generation of reactive nitrogen species4,13,14. 
Hydrogen peroxide is well known for its ability to break DNA double strands4,13. However, studies with spheroids 
treated only with H2O2 solutions in culture medium demonstrated that H2O2 alone cannot induce a long-term 
effect, even if it generates DNA damage4,20. Although H2O2 is necessary for PAM anticancer properties, other spe-
cies involved in PAM play a key role in cancer cell death. Interestingly, we previously reported that the addition 
of superoxide dismutase (SOD) to PAM reduced DNA damage in the outer layers of spheroids, highlighting the 
key role of superoxide13. These results indicate that several species found in PAM play complementary roles in 
cellular behaviors.
Others studies further investigated the mechanisms induced at the cellular scale. Oxidative stress was shown 
to induce intracellular zinc (Zn2+) release and provoke Zn2+-dependent cell death in human neuroblastoma 
SH-SY5Y cells44, while normal human fibroblasts were less susceptible to PAM cytotoxicity, probably because 
cells with low intracellular mobile Zn2+ are less susceptible to PAM cytotoxicity45. Indeed, numerous recently 
published studies have reported that PAM specifically affects tumor cells while sparing normal cells. We previ-
ously demonstrated that PAM induced selective DNA damage in HCT-116 3D spheroids compared with normal 
Figure 5. Successive treatments with PAM display cumulative effects on reducing tumor spheroid growth. At 
least 6 independent spheroids underwent a unique treatment with PAM (red squares) or two treatments (green 
triangles) or three successive treatments (blue inverted triangles), compared to control spheroid growth (black 
circles). Colored arrows indicate day of treatment with freshly produced PAM. (A) Treatments were performed 
every day. (B) Treatments were performed two days apart. *p < 0.05, **p < 0.01.
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human fibroblast GM637 spheroids4. In another study, it was shown that an optimal dose of PAM is able to 
selectively induce significant hepatocarcinoma cell apoptosis while minimizing damage to co-cultured normal 
hepatic cell lines46. This study confirms results obtained previously in two human epithelial ovarian carcinoma 
cell lines and normal fibroblasts. When treated with PAM, both types of epithelial ovarian carcinoma cell lines 
were discriminately killed through enhanced apoptosis induction, while normal fibroblast cells were not dam-
aged47. These encouraging results demonstrate that PAM could be a promising tool for anti-cancer therapy while 
sparing normal surrounding tissues.
The recognized luminescence assay48 was used to quantify intracellular ATP content after exposure to PAM. 
We proved that dramatic intracellular ATP depletion occurred early (within 1 h) after exposure to PAM. The 
finding that no ATP was measured in the supernatants indicated that ATP loss occurred due to an intracellular 
mechanism. Our observations are consistent with those of other groups for cells exposed to plasma-activated 
liquids45,49. Interestingly, to the best of our knowledge, a distinct effect was observed solely with cells directly 
exposed to cold plasmas, which led to ATP extracellular secretion50,51.
Since PAM triggers cellular damage solely in the outer layers of spheroids while sparing the core, we suggested 
the application of successive treatments to improve anti-tumor efficacy in in vivo antitumor treatment perspec-
tive. However, the duration between each new treatment proved to be important. Indeed, treatment every day did 
not show any benefits, while treatment every two days led to tumor regression. Since the induction of cell death 
is a multistep process, it seems important to allow time for cells to go through all of them before applying a new 
treatment. In cells grown in monolayer, PAM was previously shown to have an anti-tumor effect on epithelial 
ovarian carcinoma chemo-resistant cells by inducing caspases 3/7 activation within 4 h after treatment27. In mon-
olayer, PAM does not need to diffuse throughout the spheroid’s volume, meaning that all the cells grown on a flat 
surface were homogenously and directly exposed to PAM. This notion could explain why the apoptosis kinetics 
were faster in monolayers and underline the importance of successive treatments when targeting tissues in 3D.
To date, all in vivo studies with PAM27,52,53 have demonstrated a promising effect as an antitumor treatment 
in different types (solid, metastatic, liquid) of tumors. Indeed, after successive in vivo injection of fresh PAM, the 
growth of solid tumors was reduced, showing the anticancer effect of PAM in a murine model27. In this study, the 
authors showed a reduced tumor growth speed that confirmed in vivo anti-tumor effects of PAM in nude mice 
bearing ovarian cancer cells embedded in Matrigel27. Interestingly, some in vivo studies evaluated the efficacy of 
PAM administered intraperitoneally (distinct from intratumoral injections) in inhibiting peritoneal metastasis 
and showed a 60% decrease in the formation of peritoneal metastatic nodules54. Another group examined the 
effect of PAM on lymphoplasmacytic lymphoma cell lines and found that PAM induced plasma cell differentia-
tion and reduced the tumorigenic population55. A next step for in vivo treatment with PAM is to use mice with 
a functional immune system, as it has been shown that immunogenic cell death and the stimulation of mac-
rophages can improve the PAM effect56,57.
In conclusion, plasma-activated liquids may represent a novel, safe and efficient therapeutic method for the 
treatment of peritoneal metastases54, blood cancers55 and solid tumors. Furthermore, PAM preferentially activates 
cell death modalities, including apoptosis and necrosis, in tumor cell lines and primary cancerous cells compared 
with their normal counterparts. Thus, this therapeutic modality seems to offer the selectivity that is lacking in 
many other available treatments.
Materials and Methods
Low-temperature helium plasma jet production at atmospheric pressure. The plasma jet device 
is based on a dielectric barrier discharge configuration as previously described4,13,14,20. Two aluminum electrodes 
are wrapped around a quartz tube, and a generator delivers high-voltage mono-polar square pulses between them. 
The characteristics of the power supply are as follow: 10-kV voltage, 10-kHz frequency and 1-µs pulse duration. 
Helium is delivered through the quartz tube with a flow rate of 3 L/min.
Figure 6. Cascade of events leading to cell death and tumor volume reduction after PAM treatment in vitro.
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Plasma-activated medium production. PAM was produced by exposure of 100 µL of Dulbecco’s 
Modified Eagle’s Medium (DMEM) without pyruvate (Thermo Fisher Scientific, #41965) in 96-well plates to a 
low-temperature plasma jet. Cell culture medium was exposed to the plasma jet for 120 seconds. All PAM pro-
duction was performed under the same experimental setup (applied voltage, frequency, pulse duration and gas 
flow) and at the same distance between the plasma jet tube output and the upper surface of the liquid medium, 
i.e., 2 cm. PAM was freshly produced when needed for the experiments; it was not stored before use.
Cell culture. Human colorectal carcinoma cell line HCT-116 was purchased from ATCC (# CCL-247). 
These cells were chosen for their ability to produce tumor spheroids4,58,59. Cells were grown in DMEM con-
taining glucose, L-glutamine and pyruvate (Thermo Fisher Scientific, #41966), supplemented with 10% (v/v) 
heat-inactivated fetal calf serum, 100 U/ml penicillin and 100 µg/ml streptomycin. Cells were cultured at 37 °C 
in a humidified atmosphere containing 5% CO2. Cells were regularly tested (every two weeks) for mycoplasma 
contamination using the MycoAlert Mycoplasma detection kit (Lonza).
Spheroid generation. For spheroid production, 500 cells were seeded in ultralow attachment 96-well 
plates with a round bottom (Corning, Fisher Scientific) and allowed to grow for 5 days in DMEM with glucose, 
L-glutamine and pyruvate (Thermo Fisher Scientific, #41966), supplemented with 10% (v/v) heat-inactivated 
fetal calf serum, 100 U/ml penicillin and 100 µg/ml streptomycin in the incubator before use as previously 
described4,58.
Spheroid treatment with PAM. Three distinct contact times (Tcontact) of spheroids with PAM were applied: 
10 min, 4 h and 24 h. Briefly, after PAM production, spheroids were immersed in 96-well plates in 80 µl of freshly 
produced PAM for 10 min, 4 h or 24 h. After exposure to PAM, they were then immersed in fresh non-activated 
complete cell culture medium for the remaining culture time.
In the case of successive treatments, spheroids were exposed to freshly produced PAM once, two times or three 
times at one- or two-day intervals and continuously cultivated within this PAM. Their growth curve was followed 
over 9 days as described below.
Osmolarity and pH measurements. Osmolarity of PAM was measured using a cryoscopic osmometer 
(Osmomat 030; Gonotec). The osmometer was calibrated using 50 µL of solution of known osmolarity of 300 
mosmol/kg. A total of 50 µL of three independent samples were then measured for each condition (DMEM, 
PAM, He only). The pH of these solutions was measured using a microprocessor pH meter (pH 210) from Hanna 
Instruments from three independent samples for each condition (DMEM, PAM, He only).
Spheroid growth curve analysis. Growth of spheroids was followed by taking photographs with a 
wide-field light microscope before treatment and regularly after treatment for 3 or 9 days depending on the exper-
iments using a Leica DMIRB microscope coupled to a coolSNAP HQ camera (Roper Scientific, Photometrics). 
The volume of the spheroids was determined following average diameter measurements using ImageJ software 
(NIH, Bethesda, USA) as previously described4,13,20.
ATP quantification. Cell viability in spheroids was determined using the CellTiter-Glo® 3D Cell Viability 
Assay (Promega) according to the manufacturer’s instructions. Briefly, spheroids were incubated with 80 µl of 
PAM for 24 h in a 96-well white plate. At different time points, the same volume of reagent (i.e., 80 µl) was added 
to the well and incubated at room temperature under strong agitation for 30 min. Then, luminescence was read 
with a microplate reader (CLARIOstar, BMG LabTech). Alternatively, spheroids were manually removed from 
wells to quantify ATP released in the PAM supernatant. A similar procedure to that described above was applied, 
namely, addition of the same volume of reagent, incubation under agitation at room temperature and lumines-
cence quantification with a microplate reader. Finally, to assess whether reactive species generated in PAM affect 
ATP integrity, an experiment was performed with a standard solution of ATP (10 nM) incubated over 6 h in PAM.
Mitochondrial dysfunction detection. MitoSOX Red Mitochondrial SuperOxide indicator is a fluoro-
genic dye used for selective detection of superoxide in the mitochondria of living cells. Once in the mitochondria, 
this reagent is oxidized by superoxide to exhibit red fluorescence. Spheroids were immersed in 5 µM of MitoSOX 
reagent solution and incubated for 10 min at 37 °C, protected from light. MitoSOX fluorescence (λex = 510; 
λem = 580 nm) was observed within spheroids using a Leica DMIRB microscope coupled to a coolSNAP HQ 
camera (Roper Scientific, Photometrics). ImageJ software was used to process the fluorescence images.
Plasma membrane integrity determination. Propidium iodide is a probe that becomes highly fluores-
cent when intercalated within DNA60. However, it is a non-permeant probe, meaning it will only penetrate inside 
cells presenting defects in plasma membrane integrity. Briefly, at different time points after exposure to PAM, 
propidium iodide at a final concentration of 100 µM was added to the wells to label cells presenting a defect in 
plasma membrane integrity. Propidium iodide fluorescence (λex = 538; λem = 617 nm) was assessed with a Leica 
DMIRB microscope coupled to a coolSNAP HQ camera (Roper Scientific, Photometrics). ImageJ software was 
used to process fluorescence images. To quantify live propidium iodide penetration over time, spheroids exposed 
to PAM and 1 µM propidium iodide were placed within an IncuCyte ZOOM live cell imaging system (Essen 
Bioscience). Acquisitions were obtained every 30 min for one day, and quantifications were performed with the 
software associated with the videomicroscope. A movie demonstrating propidium iodide penetration into sphe-
roids exposed to PAM is available as Movie 1.
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Apoptosis detection. The Image-iT™ LIVE Red Caspase-3 and -7 Detection Kit from Molecular Probes 
was used according to the manufacturer’s protocol to visualize, by fluorescence microscopy, apoptosis induction 
in spheroids over time after exposure to PAM. Briefly, at different time points, spheroids exposed to PAM were 
incubated with FLICA kit reagent for 1 h in an incubator at 37 °C. After three washing steps in a large volume of 
PBS, the red fluorescence signal detected with a Leica DMIRB microscope coupled to a coolSNAP HQ camera is 
a direct measure of the amount of active caspase 3/7 in the treated spheroid. For convenience, images of apoptosis 
induction will be presented in green instead of red. To corroborate cell death induction through apoptosis, we 
also performed flow cytometry analysis of isolated cells from spheroids to detect precocious externalization of 
phosphatidylserine, detected with an annexin V-FITC probe while being vigilant that cells remained negative to 
propidium iodide staining. After incubation with PAM (Tcontact = 1, 4 and 6 h), spheroids were gently dissoci-
ated for 6 min in trypsin at 37 °C. For each replicate, four spheroids were dissociated and pooled to obtain enough 
cells for flow cytometry. Cells were processed according to the manufacturer’s instructions (BioVision, Mountain 
View, CA, USA). Differences between values were assessed by one-way ANOVA followed by Dunnett’s multiple 
comparisons post-test.
Statistical analysis. For every set of in vitro experiments, at least six biological replicates were analyzed. 
The reported data correspond to the means ± SEM of at least two independent experiments or to representative 
images from these experiments. Differences between data were assessed by Student’s t-test. Overall statistical 
significance was set at p < 0.05.
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